EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Dual burden of tuberculosis and human immunodeficiency virus: Outcomes and implications from Chittoor district, Andhra Pradesh

Venkataravikanth Eddula, V Sudhakar Babu, C Sravana Deepthi, Sirshendu Chaudhuri, K H Sneha

Indian Journal of Sexually Transmitted Diseases and AIDS · 2026-01 · 47 (1) · 22-26

DOI: 10.4103/ijstd.ijstd_72_25 ↗

At a glance

Journal article in Indian Journal of Sexually Transmitted Diseases and AIDS, published online on 2026-05-19. Written by Venkataravikanth Eddula and 4 co-authors. Institution: Department of Dermatology, Venereology and Leprology, Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India. 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Tuberculosis (TB) and human immunodeficiency virus (HIV) co-infection remain a significant public health challenge, particularly in resource-limited settings. This study investigates the prevalence, clinical characteristics, and treatment outcome of TB-HIV coinfected patients in Chittoor, Andhra Pradesh, India. Methodology: A retrospective cross-sectional observational study was conducted using hospital records in an antiretroviral therapy (ART) Centre of a tertiary care hospital from October 2021 to September 2023. Among 3383 registered HIV patients, 129 (3.8%) were diagnosed with TB. Clinical data, diagnostic methods, and treatment outcomes were analyzed.

Results

Most patients were males (62.0%), with a mean age of 39.7 years. Pulmonary TB was the most common type (93.0%), and 58.1% of cases were microbiologically confirmed. The median baseline and follow-up CD4 counts were 309 and 430 cells/mm 3 , respectively. TB treatment adherence was 74.6%, while 24.0% defaulted, contributing to 84.4% of the reported deaths. Incomplete isoniazid preventive therapy was a significant predictor of treatment default and mortality.

Conclusion

Despite progress in ART coverage and TB diagnosis, challenges in treatment adherence and mortality reduction persist. Strengthening diagnostic infrastructure, adherence strategies, and integrated TB-HIV care is crucial to improve outcomes in co-infected populations.

Subjects

Author keywords

Adherencecoinfectionhuman immunodeficiency virusmortalitypeople living with human immunodeficiency virustuberculosis

Authors and institutions

  • Department of Dermatology, Venereology and Leprology, Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India.
  • Department of Community Medicine, Apollo Institute of Medical Sciences and Research Chittoor, Andhra Pradesh, India.
  • Dr. Cyrus Poonawala Centre for Infectious Diseases and Pandemic Preparedness, Indian Institute of Public Health, Hyderabad, Telangana, India.
  • Department of Dermatology, Venereology and Leprology, Sri Venkateshwara Medical College, Tirupathi, Andhra Pradesh, India.

Cite

APA

Eddula, V., Babu, V. S., Deepthi, C. S., Chaudhuri, S., & Sneha, K. H. (2026). Dual burden of tuberculosis and human immunodeficiency virus: Outcomes and implications from Chittoor district, Andhra Pradesh. Indian Journal of Sexually Transmitted Diseases and AIDS, 47(1), 22-26. https://doi.org/10.4103/ijstd.ijstd_72_25

Vancouver

Eddula V, Babu VS, Deepthi CS, Chaudhuri S, Sneha KH. Dual burden of tuberculosis and human immunodeficiency virus: Outcomes and implications from Chittoor district, Andhra Pradesh. Indian Journal of Sexually Transmitted Diseases and AIDS. 2026;47(1):22-26. doi:10.4103/ijstd.ijstd_72_25

BibTeX
@article{Eddula2026,
  author = {Eddula, Venkataravikanth and Babu, V Sudhakar and Deepthi, C Sravana and Chaudhuri, Sirshendu and Sneha, K H},
  title = {Dual burden of tuberculosis and human immunodeficiency virus: Outcomes and implications from Chittoor district, Andhra Pradesh},
  journal = {Indian Journal of Sexually Transmitted Diseases and AIDS},
  year = {2026},
  volume = {47},
  number = {1},
  pages = {22--26},
  doi = {10.4103/ijstd.ijstd_72_25}
}
Start for free →